Question 1

How many shares of TAK does GLENVIEW CAPITAL MANAGEMENT, LLC own?

Accepted Answer

GLENVIEW CAPITAL MANAGEMENT, LLC previously held 0 shares of TAK (TAKEDA PHARMACEUTIC-SP ADR) before exiting the position in 2021-Q4.

Question 2

What is GLENVIEW CAPITAL MANAGEMENT, LLC's TAK position worth?

Accepted Answer

GLENVIEW CAPITAL MANAGEMENT, LLC's TAK position was last reported at $0 in 2021-Q4 before the exit.

Question 3

Is GLENVIEW CAPITAL MANAGEMENT, LLC buying or selling TAK?

Accepted Answer

In 2021-Q4, GLENVIEW CAPITAL MANAGEMENT, LLC exited their TAK position entirely (-100.0% change in shares).

Question 4

When did GLENVIEW CAPITAL MANAGEMENT, LLC first buy TAK?

Accepted Answer

Based on available 13F filings, GLENVIEW CAPITAL MANAGEMENT, LLC first reported a position in TAK in 2019-Q1. They have held the position across 12 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2021-Q4 Latest	Exited	0	-100.0%	$0	0.0%	$12.71	0
2021-Q3	Decreased	8.1M	-11.1%	$132.7M	2.4%	$15.27	0
2021-Q2	Decreased	9.1M	-43.4%	$153.4M	2.5%	$15.76	0
2021-Q1	Increased	16.1M	+5.5%	$294.1M	5.0%	$17.18	60
2020-Q4	Decreased	15.3M	-9.1%	$277.7M	6.4%	$17.02	0
2020-Q3	Increased	16.8M	+3.7%	$299.5M	9.4%	$16.98	63
2020-Q2	Decreased	16.2M	-18.9%	$290.4M	8.0%	$16.95	0
2020-Q1	Decreased	20M	-34.7%	$302.9M	8.2%	$14.63	0
2019-Q4	Increased	30.6M	+11.4%	$603.4M	5.3%	$18.41	69
2019-Q3	Increased	27.4M	+3.8%	$472M	5.0%	$16.23	61
2019-Q2	Increased	26.4M	+1.2%	$467.8M	4.2%	$16.57	59
2019-Q1	New	26.1M	-	$531.9M	4.7%	$19.07	88

TAK12 quarters

TAK
12 quarters